Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Abbas Tafakhori

Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients With Drug-Resistant Epilepsy

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2019English

CSF and Blood Biomarkers in Amyotrophic Lateral Sclerosis: Protocol for a Systematic Review and Meta-Analysis

Systematic Reviews
Medicine
2018English

Related publications

Safety and Preliminary Efficacy Analysis of the mTOR Inhibitor Ridaforolimus in Patients With Taxane-Treated, Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

Efficacy of Verapamil as an Adjunctive Treatment in Children With Drug-Resistant Epilepsy: A Pilot Study

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2014English

Long-Term Seizure Outcomes in Patients With Drug Resistant Epilepsy

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2018English

Evaluating the Safety and Efficacy of Nivolumab in Patients With Advanced Hepatocellular Carcinoma: Evidence to Date

OncoTargets and Therapy
OncologyPharmacology
2019English

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

A Noninterventional Study Evaluating the Effectiveness and Safety of Lacosamide Added to Monotherapy in Patients With Epilepsy With Partial-Onset Seizures in Daily Clinical Practice: The VITOBA Study

Epilepsia
Neurology
2015English

P.009 Characterizing Drug-Resistant Epilepsy in an Adult Cohort With New-Onset Epilepsy

Canadian Journal of Neurological Sciences
MedicineNeurology
2019English

Linezolid Safety, Tolerability and Efficacy to Treat Multidrug- And Extensively Drug-Resistant Tuberculosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Bumepamine, a Brain-Permeant Benzylamine Derivative of Bumetanide, Does Not Inhibit NKCC1 but Is More Potent to Enhance Phenobarbital’s Anti-Seizure Efficacy

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy